PetMed Express appointed Tamar Elkeles and PetMed Express stock stayed unchanged
Published on 10/08/2026 at 21:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- PetMed Express appointed Tamar Elkeles to its board on September 21, 2026.
- First-quarter fiscal 2027 revenue fell to USD 41.02 million from USD 42.82 million in the prior quarter.
- The Lang & Schwarz price was EUR 1.14 on October 8, 2026, unchanged versus the EUR 1.14 prior close.
- The next earnings date is November 10, 2026.
PetMed Express (ISIN US7163821066) was trading at EUR 1.14 at Lang & Schwarz on October 8, 2026 at 9:32 p.m. CEST, unchanged versus the prior close of EUR 1.14. On September 21, 2026, the company appointed Tamar Elkeles as an independent director and chair of its Compensation and Human Capital Committee, according to FinanzNachrichten.
Three milestones in 2026
On August 13, 2026, PetMed Express reported first-quarter fiscal 2027 revenue of USD 41.02 million, net income of minus USD 6.15 million and diluted earnings per share of minus USD 0.28, according to Investing.com.
On September 17, 2026, PetMed Express appointed Jeff Willard as chief executive officer and president, effective September 28, after he had built more than 25 years of leadership experience in consumer and e-commerce businesses, FinanzNachrichten reported.
On September 21, 2026, Elkeles joined the board with more than 30 years of executive, board and strategic advisory experience, according to FinanzNachrichten.
What does the board change mean?
The leadership sequence puts execution at the center of the PetMeds story. The first-quarter revenue of USD 41.02 million was down from USD 42.82 million in the prior quarter, a 4.21 percent sequential decline, while the quarter's net loss widened to USD 6.15 million from USD 4.06 million.
The annual comparison is harsher. Revenue for fiscal 2026 was USD 179.02 million, down 21.13 percent from USD 226.97 million in fiscal 2025, and net income was a loss of USD 57.29 million versus a loss of USD 6.27 million.
Next reporting date
The next earnings date is November 10, 2026, according to Makkler. PetMed Express is listed on NASDAQ under ticker PETS, and the latest reported quarter gives the incoming leadership team a measurable operating challenge: stabilize revenue while narrowing losses.
PETS stock stays at EUR 1.14
On Nasdaq, PETS was last at USD 1.27 on October 8, 2026 at 3:37 p.m. ET, with a 52-week range of USD 1.26 to USD 4.10 and a market capitalization of USD 27.2 million. At Lang & Schwarz, the euro price was EUR 1.14 on October 8, 2026 at 9:32 p.m. CEST, unchanged versus the prior close of EUR 1.14. The further course of trading is shown by the continuously updated real-time quote of PetMed Express stock.
PetMed Express stock facts
- Company: PetMed Express, Inc.
- ISIN: US7163821066
- Ticker: PETS
- Primary exchange: NASDAQ
- Price Lang & Schwarz as of October 8, 2026, 9:32 p.m. CEST: EUR 1.14
- Change versus prior close: unchanged
- Prior close Lang & Schwarz October 7, 2026: EUR 1.14
- Market capitalization: USD 27.2 million (as of October 8, 2026)
- 52-week range: USD 1.26-4.10 (as of October 8, 2026)
- Sector / Industry: Consumer Cyclical / Specialty Retail
- Next earnings date: November 10, 2026
Market context: Market report S&P 500.
